ALLIENT INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALLIENT INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	246	252	311	371	367	404	503	579	530	554
Cost of revenue	173	176	219	259	258	282	346	395	364	373
Gross profit	73	75.7	91.4	113	109	121	157	184	166	182
Selling and marketing	9.99	11	11.8	16.5	15.4	17.2	21.9	24.7	25.3	24.5
General and administrative	24.3	24.9	32	37.7	38.3	42.4	50.7	58.4	55.7	57.9
Operating expenses	54.1	56.9	68.2	83.1	85.6	95	126	141	136	138
Operating income	18.9	18.8	23.2	29.4	23	26	31.7	42.3	30	44
Interest expense	6.45	2.47	2.7	5.13	3.72	3.24	7.69	12.4	13.3	13.2
Other non-operating income	-6.08	-2.66	-2.55	-5.6	-4.22	-2.91	-7.98	-12.6	-13.2	-15.3
Pre-tax income	12.8	16.1	20.7	23.8	18.8	23.1	23.7	29.7	16.9	28.7
Income tax	3.73	8.1	4.76	6.82	5.13	-0.98	6.29	5.6	3.69	6.7
Net income	9.08	8.04	15.9	17	13.6	24.1	17.4	24.1	13.2	22
EBITDA	28.6	29.1	34.8	44.3	39	44.1	57.1	67.4	55.9	69.4
EPS, basic	0.67	0.59	1.15	1.21	0.96	1.67	1.13	1.51	0.80	1.32
EPS, diluted	0.67	0.58	1.13	1.20	0.95	1.66	1.09	1.48	0.79	1.32
Shares, basic (weighted)	13.5	13.7	13.9	14.1	14.2	14.4	15.4	16	16.5	16.7
Shares, diluted (weighted)	13.7	13.9	14.1	14.2	14.3	14.5	16	16.3	16.6	16.7
Dividend per share	0.07	0.07	0.08	0.08	0.08	0.10	0.10	0.12	0.12	0.12

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	15.5	15.6	8.67	13.4	23.1	22.5	30.6	31.9	36.1	40.7
Receivables	26.1	31.8	43.2	44.4	47.4	51.2	76.2	85.1	78.8	88.8
Inventory	31.1	32.6	55	53.4	63	89.7	117	118	112	109
Other current assets	3.12	3.46	4	4.41	8.73	12.5	12.1	13.4	11.2	14.8
Total current assets	75.8	83.4	111	116	142	176	236	248	238	253
Property, plant and equipment	37.5	38.4	48	53	55.4	57	68.6	67.5	65.7	61.8
Lease right-of-use assets				16.4	19	17	22.8	24	23.7	21
Goodwill	27.5	29.5	52.6	52.9	61.9	107	126	131	132	134
Intangible assets	34.3	32.1	68.4	62.5	65.9	104	119	111	99.7	88.4
Other non-current assets	3.94	4.46	5.04	4.84	4.48	5.12	11.3	7.43	8.19	8.13
Total assets	180	188	285	306	349	471	588	598	576	578
Accounts payable	13.2	15.4	25.9	23.6	27.7	36.7	39.5	39.1	27.2	28.4
Accrued liabilities	10.7	14.3	18.7	23	24.9	41.7	48.1	56.5	30.2	40.9
Deferred revenue						2.43	4.81	2.14	2.29	3.77
Short-term debt	0.94	0.46
Total current liabilities	24.8	30.1	44.6	46.6	52.5	78.4	87.6	95.6	57.4	69.3
Long-term debt	70.5	52.7	123	110	120	159	235	218	224	180
Lease liabilities				13.7	15	12.8	18.8	19.5	19.4	16.4
Other non-current liabilities	4.69	9.52	8.23	7.98	8.56	23.9	21.8	5.4	4.65	6.76
Total liabilities	108	101	183	187	206	283	373	346	311	276
Total debt	70.5	52.7	123	110	120	159	235	218	224	180
Retained earnings	54.8	61.9	76.7	92.6	105	128	144	166	177	197
Other comprehensive income	-12	-5.59	-8.52	-10.5	-3.29	-8.09	-12	-10.2	-23.2	-9.53
Shareholders' equity	72.3	87.3	102	119	143	188	215	252	265	301
Total equity	72.3	87.3	102	119	143	188	215	252	265	301
Total liabilities and equity	180	188	285	306	349	471	588	598	576	578
Shares outstanding	0.01	0.01	14.2	9.6	14.6	15.4	16	16.3	16.8	16.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	9.08	8.04	15.9	17	13.6	24.1	17.4	24.1	13.2	22
Depreciation and amortization	9.75	10.3	11.6	14.9	16	18.1	25.5	25.1	25.9	25.4
Stock-based compensation				3.2	3.55	4.16	5.07	5.48	4.15	3.43
Deferred income tax	1.77	0.78	-0.08	-0.11	-0.52	-6.14	-3.72	-5.04	-2.35	-1.47
Change in receivables	-3.72	-4.05	-4.11	-1.46	2.71	-0.17	-22.2	-5.57	7.46	-7.89
Change in inventory	-0.93	0.02	-17.3	0.07	-4.69	-22.9	-27.8	-1.78	7.36	3.32
Change in payables	-0.96	1.28	6.53	-1.81	-1.87	8.29	2.79	-0.94	-12.8	0.18
Cash from operations	14.3	25.4	17.5	34.5	24.8	25.4	5.6	45	41.9	56.7
Capital expenditures	-5.19	-6.2	-14.3	-14.9	-9.37	-13.7	-15.9	-11.6	-9.68	-6.99
Acquisitions	-16.2		-77.4		-14.7	-47.3	-44.1	-11	-25.2
Cash from investing	-21.4	-6.2	-91.7	-14.9	-24.1	-61	-60	-22.6	-34.9	-6.99
Debt issued	76.3		83.2	9.64	27	51.4	74.7	11	76.9
Debt repaid	-67.1	-18.4	-13.3	-22.5	-16.9	-12.2
Dividends paid	-0.94	-0.96	-1.08	-1.17	-1.16	-1.37	-1.54	-1.83	-1.98	-2
Cash from financing	1.58	-20.2	67.8	-14.8	7.49	35.8	63.6	-21.3	-0.84	-47.7
Exchange rate effect			-0.4	-0.13	1.49	-0.93	-1.04	0.17	-1.89	2.61
Net change in cash	-5.8	0.11	-6.92	4.74	9.72	-0.67	8.15	1.29	4.2	4.6
Free cash flow	9.12	19.2	3.12	19.6	15.5	11.7	-10.3	33.4	32.2	49.7
Interest paid	5.05	2.26	2.27	5.34	3.59	3.06	7.3	12.2	12.1	13
Income taxes paid	1.15	2.09	7.01	2.05	8.56	3.87	7.5	12.7	7.8	8.99

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $116.01 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	33.3%	Gross profit / revenue.
Operating margin	8.4%	Operating income / revenue.
EBITDA margin	11.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	6.4%	Pre-tax income / revenue.
Net margin	5.0%	Net income / revenue.
FCF margin	4.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.7%	Cash from operations / revenue.
Effective tax rate	22.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.8%	Net income / average total assets.
Return on invested capital (ROIC)	8.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	3.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	9.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	4.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	46.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	11.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	13.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	24.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	6.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	12.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	67.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	8.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	10.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	67.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	6.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	6.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	35.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	116.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	17.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	54.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	26.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.3%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	8.4%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	13.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	11.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	16.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-0.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.42x	Current assets / current liabilities.
Quick ratio	1.77x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.52x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.56x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	29.2%	Total debt / total assets.
Liabilities / assets	47.4%	Total liabilities / total assets.
Net debt	$131.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.95x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.38x	Operating income / interest expense.
Working capital	$194.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	36.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$97.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.97x	Revenue / average total assets.
Fixed asset turnover	9.22x	Revenue / average property, plant and equipment.
Inventory turnover	3.25x	Cost of revenue / average inventory.
Days inventory	112 days	365 x average inventory / cost of revenue.
Receivables turnover	5.76x	Revenue / average receivables.
Days sales outstanding	63 days	365 x average receivables / revenue.
Days payables	41 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	135 days	Days inventory + days sales outstanding - days payables.
FCF conversion	96.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	28.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.70	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$34.06	Revenue / diluted weighted shares.
FCF per share	$1.63	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.27	Cash from operations / diluted weighted shares.
Book value per share	$18.38	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.75	Tangible book value / shares outstanding.
Cash per share	$2.48	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.97B	Share price x shares outstanding.
Enterprise value	$2.10B	Market cap + total debt - cash - short-term investments.
P/E	68.9x	Market cap / net income. Only when net income is positive.
P/S	3.43x	Market cap / revenue.
P/B	6.32x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	20.2x	Market cap / tangible book value, when positive.
P/FCF	71.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	51.4x	Market cap / cash from operations, when positive.
EV/Sales	3.66x	Enterprise value / revenue.
EV/EBIT	43.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	31.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	76.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.4%	Free cash flow / market cap.
Earnings yield	1.5%	Net income / market cap (the inverse of P/E).
PEG	10.5x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ALLIENT INC's revenue in fiscal 2025?

ALLIENT INC reported revenue of $554.5M for fiscal 2025, 4.6% higher than the year before.

Was ALLIENT INC profitable in fiscal 2025?

Yes. Net income was $22.0M, a net margin of 4%.

How much free cash flow did ALLIENT INC generate in fiscal 2025?

Cash from operations of $56.7M minus capital expenditures of $7.0M left free cash flow of $49.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ALLIENT INC